- Home
- BNZI vs EVOK Comparison
BNZI vs EVOK Comparison
Compare BNZI & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- EVOK
- Stock Information
- Founded
- BNZI 2016
- EVOK 2007
- Country
- BNZI United States
- EVOK United States
- Employees
- BNZI N/A
- EVOK N/A
- Industry
- BNZI
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- EVOK Health Care
- Exchange
- BNZI Nasdaq
- EVOK Nasdaq
- Market Cap
- BNZI 11.5M
- EVOK 4.2M
- IPO Year
- BNZI N/A
- EVOK 2013
- Fundamental
- Price
- BNZI $4.90
- EVOK $7.29
- Analyst Decision
- BNZI Strong Buy
- EVOK
- Analyst Count
- BNZI 1
- EVOK 0
- Target Price
- BNZI $24.00
- EVOK N/A
- AVG Volume (30 Days)
- BNZI 4.2M
- EVOK 16.1K
- Earning Date
- BNZI 08-13-2025
- EVOK 08-12-2025
- Dividend Yield
- BNZI N/A
- EVOK N/A
- EPS Growth
- BNZI N/A
- EVOK N/A
- EPS
- BNZI N/A
- EVOK N/A
- Revenue
- BNZI $6,827,490.00
- EVOK $11,594,083.00
- Revenue This Year
- BNZI $570.18
- EVOK $57.82
- Revenue Next Year
- BNZI $34.44
- EVOK $59.12
- P/E Ratio
- BNZI N/A
- EVOK N/A
- Revenue Growth
- BNZI 52.95
- EVOK 89.89
- 52 Week Low
- BNZI $0.54
- EVOK $1.94
- 52 Week High
- BNZI $11.20
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- BNZI 29.94
- EVOK 88.44
- Support Level
- BNZI $4.11
- EVOK $2.52
- Resistance Level
- BNZI $6.90
- EVOK $2.84
- Average True Range (ATR)
- BNZI 0.66
- EVOK 0.38
- MACD
- BNZI -0.03
- EVOK 0.30
- Stochastic Oscillator
- BNZI 23.09
- EVOK 65.10
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.